Skip to main content
Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
69.50
+0.20 (0.29%)
Mar 31, 2025, 3:51 PM EST

Novo Nordisk Revenue

In the year 2024, Novo Nordisk had annual revenue of 290.40B DKK with 25.03% growth. Novo Nordisk had revenue of 85.68B in the quarter ending December 31, 2024, with 30.09% growth.

Revenue
290.40B DKK
Revenue Growth
+25.03%
P/S Ratio
n/a
Revenue / Employee
3.75M DKK
Employees
77,349
Market Cap
305.46B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
SS Innovations International 16.04M
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
Northwest Biotherapeutics 1.60M
Silence Therapeutics 43.26M
American Oncology Network 1.76B
Revenue Rankings

Novo Nordisk News

More News